Horizon Investments’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-2,324
Closed -$389K 572
2019
Q2
$389K Sell
2,324
-21,151
-90% -$2.93M 0.01% 311
2019
Q1
$3.44M Buy
23,475
+7,867
+50% +$1.14M 0.12% 70
2018
Q4
$2.09M Buy
15,608
+4,668
+43% +$765K 0.11% 83
2018
Q3
$2.08M Sell
10,940
-1,732
-14% -$318K 0.07% 86
2018
Q2
$2.11M Buy
+12,672
New +$2.03M 0.09% 72
2016
Q3
Sell
-2,219
Closed -$513K 155
2016
Q2
$513K Buy
+2,219
New +$512K 0.04% 83

Other funds holding AGN

Horizon Investments's AGN Position: Q3 2019 in Review

Horizon Investments sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 2,324 shares — an estimated $389K sold.

Horizon Investments first reported a position in AGN in Q2 2016 and held it in 6 quarters. The position peaked at $3.44M in Q1 2019. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Horizon Investments reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Horizon Investments sold 2,324 Allergan plc shares in Q3 2019, an estimated $389K.
  • Horizon Investments first reported a position in Allergan plc in Q2 2016 and held it in 6 quarters.
  • Horizon Investments's Allergan plc position peaked at $3.44M in Q1 2019.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Horizon Investments's 13F filing for Q3 2019, filed 14 Nov 2019.